Research To Practice | Oncology Videos

Research To Practice
  • ٠٫٠ (٠)
  • العلوم
  • يتم التحديث أسبوعيًا
Research To Practice | Oncology Videos

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.

  1. قبل ٥ أيام

    Lymphoma | Gilles Salles, MD, PhD

    What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma — Gilles Salles, MD, PhD CME information and select publications

    ٢٣ من الدقائق

  2. قبل ٥ أيام

    Lymphoma | What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma

    Featuring an interview with Dr Gilles Salles, including the following topics: Epigenetic modifications and the role of EZH2 in the pathobiology of follicular lymphoma (FL) (0:00) Natural history of FL and current treatment landscape in the first-line setting (5:20) Testing approaches for the detection of EZH2 mutations (14:37) Mechanism of action of the EZH inhibitors tazemetostat and valemetostat (18:31) Tazemetostat monotherapy as treatment for relapsed/refractory FL (20:58) Ongoing evaluation of novel treatment approaches with tazemetostat for FL and other lymphomas (25:31) Approved indications for tazemetostat for wild-type FL and FL with EZH2 mutations; sequencing of tazemetostat with bispecific antibodies and CAR T-cell therapy (34:07) Available clinical data with the novel dual EZH1/EZH2 inhibitor valemetostat (42:37) Personal experience with CAR T-cell therapy and perspectives on possible underlying reasons for the development of T-cell lymphoma in patients receiving this treatment (44:35) Management of FL in patients who experience relapse within 24 months of receiving treatment (POD24) (48:25) Myths or misperceptions associated with tazemetostat and other therapies approved in the relapsed FL setting (52:15) Perspectives on the future treatment landscape of FL (54:29) CME information and select publications

    ٥٦ من الدقائق

  3. قبل ٦ أيام

    Lung Cancer | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from Recent Major Conferences

    Featuring an interview with Dr Stephen V Liu, including the following topics: Management of localized non-small cell lung cancer (NSCLC) (0:00) First-line treatment of advanced NSCLC (10:53) Targeted therapy for patients with NSCLC and actionable genomic alterations (30:24) Recent FDA approvals for NSCLC (37:49) Recent advances in small cell lung cancer (47:14) Lurbinectidin in combination with atezolizumab as front-line maintenance therapy for patients with early-stage SCLC (52:33) CME information and select publications

    ٥٤ من الدقائق

  4. ٤ جمادى الأولى

    Gastrointestinal Cancers | The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review

    Featuring perspectives from Dr Tanios Bekaii-Saab and Dr Philip A Philip, including the following topics: Introduction (0:00) Colorectal Cancer, Anal Cancer and Pancreatic Cancer — Dr Philip (1:56) Gastroesophageal Cancers, Hepatocellular Cancer and Biliary Tract Cancers — Dr Bekaii-Saab (41:48) CME information and select publications

    ١ س ٢ د

  5. ٢٩ ربيع الآخر

    Metastatic Breast Cancer | Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer

    Featuring perspectives from Prof Francois-Clement Bidard and Dr Kevin Kalinsky, including the following topics: Introduction: Confronting Metastatic Breast Cancer (mBC) (0:00) Mechanisms of Resistance to Endocrine Therapy in HR-Positive mBC; Use of Oral Selective Estrogen Receptor Degraders (SERDs) — Dr Kalinsky (13:18) Ongoing Evaluation of Early Therapeutic Switching for HR-Positive mBC Harboring ESR1 Mutations — Prof Bidard (35:52) CME information and select publications

    ٥٩ من الدقائق

  6. ٢٧ ربيع الآخر

    Mantle Cell Lymphoma | Michael Wang, MD

    Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma | Faculty Presentation — Michael Wang, MD CME information and select publications.

    ٥٣ من الدقائق

  7. ٢٧ ربيع الآخر

    Mantle Cell Lymphoma | Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma

    Featuring perspectives from Dr Tycel Phillips and Dr Michael Wang, including the following topics: Introduction: Interface Between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma (0:00) Key Datasets — Overview and First-Line Therapy (7:16) Faculty Case Presentations — Dr Phillips (27:03) Key Datasets — Relapsed/Refractory Disease (35:40) Faculty Case Presentations — Dr Wang (48:06) CME information and select publications

    ٥٨ من الدقائق

  8. ٢٢ ربيع الآخر

    HR-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer (Companion Faculty Lecture)

    Featuring a slide presentation and related discussion from Dr Erika Hamilton, including the following topics: Targeted therapies for ER-positive breast cancer (0:00) Clinical data with oral selective estrogen receptor degraders (2:13) Biological rationale for and mechanism of action of proteolysis-targeting chimeras (PROTACs) (7:07) Emerging data with PROTACs for ER-positive advanced breast cancer (9:17) Future directions with PROTACs for breast cancer (19:21) CME information and select publications

    ٢٣ من الدقائق
مشاهدة الكل (١٫٤ ألف)

حول

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.

المعلومات

  • قناة
    Research To Practice
  • صناع العمل
    Dr Neil Love
  • سنوات النشاط
    ١٤٣٤ هـ - ١٤٤٦ هـ
  • الحلقات
    ١٫٤ ألف
  • التقييم
    ملائم
  • حقوق النشر
    Copyright © 2023 Research To Practice. All Rights Reserved.
  • موقع البرنامج على الويب
    Research To Practice | Oncology Videos

المزيد من Research To Practice

  • Lung Cancer Update
    العلوم
    العلوم

    يتم التحديث كل أسبوعين

  • Dermatologic Oncology Update
    العلوم
    العلوم

    يتم التحديث كل شهرين

  • Oncology Today with Dr Neil Love
    طب
    طب

    يتم التحديث أسبوعيًا

  • Breast Cancer Update
    العلوم
    العلوم

    يتم التحديث شهريًا

  • Gynecologic Oncology Update
    العلوم
    العلوم

    ١٨ صفر

  • Prostate Cancer Update
    العلوم
    العلوم

    يتم التحديث كل شهرين

  • Gastrointestinal Cancer Update
    العلوم
    العلوم

    مرتان في الشهر

قد يعجبك أيضًا

  • Oncology Today with Dr Neil Love
    طب
    طب

    يتم التحديث أسبوعيًا

  • Breast Cancer Update
    العلوم
    العلوم

    يتم التحديث شهريًا

  • Hematologic Oncology Update
    العلوم
    العلوم

    يتم التحديث كل أسبوعين

  • NEJM This Week
    طب
    طب

    يتم التحديث أسبوعيًا

  • The Curbsiders Internal Medicine Podcast
    طب
    طب

    يتم التحديث أسبوعيًا

  • Harrison's PodClass: Internal Medicine Cases and Board Prep
    طب
    طب

    ٢٨ ربيع الآخر

  • The Clinical Problem Solvers
    دورات تدريبية
    دورات تدريبية

    يتم التحديث أسبوعيًا

للاستماع إلى حلقات ذات محتوى فاضح، قم بتسجيل الدخول.

اطلع على آخر مستجدات هذا البرنامج

قم بتسجيل الدخول أو التسجيل لمتابعة البرامج وحفظ الحلقات والحصول على آخر التحديثات.
تحديد بلد أو منطقة

أفريقيا والشرق الأوسط، والهند

آسيا والمحيط الهادئ

أوروبا

أمريكا اللاتينية والكاريبي

الولايات المتحدة وكندا